Amarantus is a biotechnology company focused on discovering and developing biologics to treat and/or diagnose Parkinson’s disease, Alzheimer’s disease, Traumatic Brain Injury, and other human diseases. The company has an exclusive worldwide license to the Lymphocyte Proliferation test for Alzheimer’s disease and owns the intellectual property rights to a therapeutic protein it is developing to treat various protein folding-related medical conditions. For more information, visit the company’s website at www.amarantus.com.